Harrow Health, Inc. ( NASDAQ:HROW – Get Free Report ) CEO Mark L. Baum purchased 5,800 shares of the firm's stock in a transaction on Monday, August 14th. The stock was bought at an average price of $17.05 per share, for a total transaction of $98,890.00. Following the completion of the transaction, the chief executive officer now directly owns 2,015,461 shares in the company, valued at $34,363,610.05. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website .

https://www.dailypolitical.com/2023/08/15/mark-l-baum-buys-5800-shares-of-harrow-health-inc-nasdaqhrow-stock.html

#dailypolitical